Prostate cancer: ESMO Consensus Conference Guidelines 2012

被引:115
作者
Horwich, A. [1 ]
Hugosson, J. [2 ]
de Reijke, T. [3 ]
Wiegel, T. [4 ]
Fizazi, K. [5 ]
Kataja, V. [6 ]
机构
[1] Royal Marsden Hosp, Dept Radiotherapy, Inst Canc Res, Sutton SM2 5PT, Surrey, England
[2] Univ Gothenburg, Dept Urol, Sahlgrenska Acad, Gothenburg, Sweden
[3] Univ Amsterdam, Acad Med Ctr, Dept Urol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Ulm Klinikum, Klin Strahlentherapie & Radioonkol, Dept Radiooncol, Ulm, Germany
[5] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[6] Kuopio Univ Hosp, Ctr Canc, SF-70210 Kuopio, Finland
关键词
consensus; ESMO; prostate cancer; ANDROGEN-DEPRIVATION THERAPY; PHASE-III TRIAL; INTENSITY-MODULATED RADIOTHERAPY; MITOXANTRONE PLUS PREDNISONE; CONFORMAL RADIATION-THERAPY; DIGITAL RECTAL EXAMINATION; DOSE-RATE BRACHYTHERAPY; LYMPH-NODE DISSECTION; I CLINICAL-TRIAL; QUALITY-OF-LIFE;
D O I
10.1093/annonc/mds624
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological aspects. Before the conference, the expert panel prepared clinically relevant questions about prostate cancer in four areas for discussion as follows: diagnosis and staging, management of early localized disease, management of advanced localized disease and systemic disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.
引用
收藏
页码:1141 / 1162
页数:22
相关论文
共 202 条
[81]   Three-Tesla Magnetic Resonance-Guided Prostate Biopsy in Men With Increased Prostate-Specific Antigen and Repeated, Negative, Random, Systematic, Transrectal Ultrasound Biopsies: Detection of Clinically Significant Prostate Cancers [J].
Hoeks, Caroline M. A. ;
Schouten, Martijn G. ;
Bomers, Joyce G. R. ;
Hoogendoorn, Stefan P. ;
Hulsbergen-van de Kaa, Christina A. ;
Hambrock, Thomas ;
Vergunst, Henk ;
Sedelaar, J. P. Michiel ;
Futterer, Jurgen J. ;
Barentsz, Jelle O. .
EUROPEAN UROLOGY, 2012, 62 (05) :902-909
[82]   Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Horwich, A. ;
Parker, C. ;
Bangma, C. ;
Kataja, V. .
ANNALS OF ONCOLOGY, 2010, 21 :v129-v133
[83]   Ten-year follow-up of radiation therapy oncology group protocol 92-02: A phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer [J].
Horwitz, Eric M. ;
Bae, Kyounghwa ;
Hanks, Gerald E. ;
Porter, Arthur ;
Grignon, David J. ;
Brereton, Harmar D. ;
Venkatesan, Varagur ;
Lawton, Colleen A. ;
Rosenthal, Seth A. ;
Sandler, Howard M. ;
Shipley, William U. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2497-2504
[84]   High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial [J].
Hoskin, Peter J. ;
Motohashi, Kate ;
Bownes, Peter ;
Bryant, Linda ;
Ostler, Peter .
RADIOTHERAPY AND ONCOLOGY, 2007, 84 (02) :114-120
[85]   The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer:: a meta-analysis [J].
Hovels, A. M. ;
Heesakkers, R. A. M. ;
Adang, E. M. ;
Jager, G. J. ;
Strum, S. ;
Hoogeveen, Y. L. ;
Severens, J. L. ;
Barentsz, J. O. .
CLINICAL RADIOLOGY, 2008, 63 (04) :387-395
[86]   Outcome of surgery for clinical unilateral T3a prostate cancer: A single-institution experience [J].
Hsu, Chao-Yu ;
Joniau, Steven ;
Oyen, Raymond ;
Roskams, Tania ;
Van Poppel, Hein .
EUROPEAN UROLOGY, 2007, 51 (01) :121-129
[87]   Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy [J].
Hu, Jim C. ;
Gu, Xiangmei ;
Lipsitz, Stuart R. ;
Barry, Michael J. ;
D'Amico, Anthony V. ;
Weinberg, Aaron C. ;
Keating, Nancy L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (14) :1557-1564
[88]   Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer [J].
Huber, Marie L. ;
Haynes, Laura ;
Parker, Chris ;
Iversen, Peter .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (04) :273-279
[89]   Results of a randomized, population-based study of biennial screening using serum prostate-specific antigen measurement to detect prostate carcinoma [J].
Hugosson, J ;
Aus, G ;
Lilja, H ;
Lodding, P ;
Pihl, CG .
CANCER, 2004, 100 (07) :1397-1405
[90]   Mortality results from the Goteborg randomised population-based prostate-cancer screening trial [J].
Hugosson, Jonas ;
Carlsson, Sigrid ;
Aus, Gunnar ;
Bergdahl, Svante ;
Khatami, Ali ;
Lodding, Par ;
Pihl, Carl-Gustaf ;
Stranne, Johan ;
Holmberg, Erik ;
Lilja, Hans .
LANCET ONCOLOGY, 2010, 11 (08) :725-732